Cited by 12Wound Healing and TreatmentsHydrogels: synthesis, properties, applicationsDiabetic Foot Ulcer Assessment and Management

An injectable ibuprofen sustained-release composite hydrogel system effectively accelerates diabetic wound healing via anti-inflammatory effects and angiogenesis

Open access
Li, Zhibin, Dong, Haijiang, Yang, Shenyu, Wang, Ximei, Li, Zhen·2025·International Journal of Nanomedicine

Abstract

Purpose: Excessive inflammation in diabetic wounds, driven by hyperglycemia, prolongs healing, increases the risk of non-healing ulcers, and can lead to severe complications such as amputation or life-threatening infections. Recurrent wound infections and prolonged treatment impose significant economic and psychological burdens, drastically reducing patients' quality of life. Modulating the inflammatory response is a promising strategy to accelerate diabetic wound healing. Ibuprofen (IBU), a widely used anti-inflammatory and analgesic agent, has the potential to promote healing by mitigating excessive inflammation and alleviating wound-associated pain. However, its clinical application is hindered by poor water solubility and a short half-life. Therefore, a controlled and sustained-release system for IBU could enhance its therapeutic efficacy in diabetic wound management. Materials and Methods: ) via ion crosslinking, photocrosslinking, and Schiff-base reactions. Results: The optimized hydrogel formulation was synthesized at 35°C, with a P/A molar ratio of 2 and an methacrylamide(MA) volume fraction of 20%. Physicochemical and biocompatibility analyses demonstrated that the IBU-loaded composite hydrogel exhibits enhanced mechanical strength, favorable biocompatibility, tunable degradation, and injectability. This system effectively addresses IBU's solubility and absorption challenges while conforming to wounds of varying shapes and sizes, enabling controlled and sustained drug release. Cellular and animal studies confirmed that the hydrogel continuously and uniformly releases IBU, exerting anti-inflammatory effects while promoting angiogenesis and fibroblast migration. This leads to enhanced granulation tissue formation, collagen deposition, and epidermal regeneration, significantly accelerating wound closure within 14 days. Conclusion: By simultaneously suppressing inflammation and stimulating tissue regeneration through controlled IBU release, this hydrogel system offers a highly effective strategy for diabetic wound healing and holds strong potential for clinical application.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2147/ijn.s504924

Cites

61 of 61 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The combination of 90% amino substitution degree GelMA and 10% w/v concentration (GM90-10%) was selected for its optimal mechanical properties, biocompatibility, and photocrosslinking efficiency, which has become the mainstream choice for tissue engineering, 3D printing, and cell culture.

    “For GelMA hydrogel preparation, the combination of 90 % amino substitution degree GelMA and 10 % w/v concentration (GM90-10 %) was selected for its optimal mechanical properties, biocompatibility, and photocrosslinking efficiency, which has become the mainstream choice for tissue engineering, 3D printing, and cell culture [47,48].”

    From Hydrogel scaffold encapsulating MSC-Exos and ZIF-8 promotes bone regeneration via coordinating osteogenesis and immunomodulation (2025) · cites this paper as [48]

    Split into 2 atoms — 0 confirmed, 2 partially supported, 0 disputed, 0 misattributed, 0 unverifiable. Expand the claim to see per-atom verdicts.

    Experimental — accuracy not yet measured

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Li, Z., Dong, H., Yang, S., Wang, X., & Li, Z.
Affiliations
First Affiliated Hospital of Zhengzhou University (CN)
Corresponding author
Li, Zhen
Venue
International Journal of Nanomedicine
Published
2025-04
Volume
Volume 20
Pages
4535-4550
ISSN
  • 1176-9114 (ISSN-L)
  • 1178-2013
OpenAlex
W4409367188
Cited by
12
References
58
Citations by year
2026: 6 · 2025: 6
FWCI
4.08
Type
journal article
Language
en
Open access
Locations
  • International Journal of Nanomedicine (publishedVersion, cc-by-nc)
  • Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
  • PubMed Central (publishedVersion, cc-by-nc)
  • PubMed (publishedVersion)
  • Dove Medical Press (Taylor and Francis Group) (submittedVersion, cc-by-nc)
Topics
  • Health Sciences › Medicine › Rehabilitation › Wound Healing and Treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Medicine › Hydrogels: synthesis, properties, applications
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
Keywords
ibuprofen, diabetic wound healing, composite hydrogels, sustained drug release, anti-inflammatory therapy, angiogenesis, ionic crosslinking, photocrosslinking, Schiff base, injectable hydrogel, fibroblast migration, collagen deposition, epidermal regeneration, hyperglycemia
MeSH terms
Angiogenesis, Alginates, Animals, Anti-Inflammatory Agents, Delayed-Action Preparations, Diabetes Mellitus, Experimental, Gelatin, Humans, Ibuprofen, Male, Wound Healing, Neovascularization, Physiologic, Hydrogels, beta-Cyclodextrins, Mice, Rats, Drug Liberation

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review